Return to homepagePandemic Pact

Global Health Security Research & Development Programme.

  • Funded by Foreign, Commonwealth & Development Office (FCDO)
  • Total publications:0 publications

Grant number: GB-GOV-1-301542-402

Grant search

Key facts

  • Disease

    Ebola, mpox

  • Start & end year

    2023
    2027

  • Known Financial Commitments (USD)

    $2,573,606.26

  • Funder

    Foreign, Commonwealth & Development Office (FCDO)

  • Principal Investigator

    N/A

  • Research Location

    Norway

  • Lead Research Institution

    Coalition for Epidemic Preparedness Innovations (CEPI)

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

  • Mpox Research Priorities

    N/A

  • Mpox Research Sub Priorities

    N/A

Abstract

General: This project relates to the programme funded staff supporting delivery of the overall programme. They provide specialist technical and programme support expertise to ensure the programme funds high quality research to help low and middle-income countries prepare/prevent/respond to health crises. The overall project is supporting research to produce evidence and develop new technologies (e.g. vaccines, diagnostics, and treatments) to tackle emerging and epidemic disease threats (such as Ebola, Mpox and Cholera) in low- and middle-income countries. This project will help ensure the overall programme delivers on its objective to develop new tools which are affordable and accessible in the poorest countries, especially in Sub Saharan Africa.; General: This project relates to the programme funded staff supporting delivery of the overall programme. They provide specialist technical and programme support expertise to ensure the programme funds high quality research to help low and middle-income countries prepare/prevent/respond to health crises. The overall project is supporting research to produce evidence and develop new technologies (e.g. vaccines, diagnostics, and treatments) to tackle emerging and epidemic disease threats (such as Ebola, Mpox and Cholera) in low- and middle-income countries. This project will help ensure the overall programme delivers on its objective to develop new tools which are affordable and accessible in the poorest countries, especially in Sub Saharan Africa.